BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Synchronicity - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Synchronicity
X-ORIGINAL-URL:https://syncconference.org
X-WR-CALDESC:Events for Synchronicity
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260319T160000
DTEND;TZID=America/New_York:20260319T173000
DTSTAMP:20260507T031941
CREATED:20260120T154118Z
LAST-MODIFIED:20260309T145438Z
UID:10000128-1773936000-1773941400@syncconference.org
SUMMARY:Testing and Treatment Services for HIV\, STIs\, and Hepatitis C at Substance Use Treatment Facilities Serving Clients in the Ending the HIV Epidemic Priority Jurisdictions of the U.S.
DESCRIPTION:Substance use and substance use disorders (SUD) are well-known risk factors for elevated incidence of HIV\, sexually transmitted infections (STIs) and Hepatitis C (HCV). Regular\, accessible testing for HIV\, STIs\, and HCV is critical to controlling spread through early identification and prompt treatment. The array of treatment options for HIV and HCV has dramatically expanded with multiple regimens for each\, many of which are curative for HCV. Pre-exposure prophylaxis (PrEP) is highly-effective for HIV prevention. In 2019\, the U.S. designated 50 counties and cities as priority jurisdictions for intervention within the Ending the HIV Epidemic (EHE) initiative due to their high incidence of new infections. In this study\, we utilized publicly available data to investigate availability of testing for HIV\, STIs\, and HCV and treatment for HIV\, HCV\, and PrEP for HIV prevention at over 5\,000 substance use treatment facilities operating in the EHE priority jurisdictions. As frequent points of healthcare system contact for people with SUD\, these treatment facilities present an opportunity to make meaningful progress in ending the HIV\, STI\, and HCV epidemics through expansion of testing and treatment services. This session presents data from the National Substance Use and Mental Health Services Survey (2023) conducted by the Substance Abuse and Mental Health Services Administration to present the current state of availability of testing and treatment services for HIV\, HCV\, and STIs. Specific opportunities for seamless integration of these services leveraging the existing care provided for SUD to integrate screening and treatment for viral and infectious diseases.
URL:https://syncconference.org/agenda/testing-and-treatment-services-for-hiv-stis-and-hepatitis-c-at-substance-use-treatment-facilities/
LOCATION:Studio C
CATEGORIES:Track Session
ATTACH;FMTTYPE=image/jpeg:https://syncconference.org/wp-content/uploads/2026/01/TrackHero-HIVCareTreatment.jpg
END:VEVENT
END:VCALENDAR